Titlebook: Global Virology III: Virology in the 21st Century; Paul Shapshak,Seetharaman Balaji,John T. Sinnott Book 2019 Springer Nature Switzerland

鳥場(chǎng)

書目名稱Global Virology III: Virology in the 21st Century影響因子(影響力)




書目名稱Global Virology III: Virology in the 21st Century影響因子(影響力)學(xué)科排名




書目名稱Global Virology III: Virology in the 21st Century網(wǎng)絡(luò)公開度




書目名稱Global Virology III: Virology in the 21st Century網(wǎng)絡(luò)公開度學(xué)科排名




書目名稱Global Virology III: Virology in the 21st Century被引頻次




書目名稱Global Virology III: Virology in the 21st Century被引頻次學(xué)科排名




書目名稱Global Virology III: Virology in the 21st Century年度引用




書目名稱Global Virology III: Virology in the 21st Century年度引用學(xué)科排名




書目名稱Global Virology III: Virology in the 21st Century讀者反饋




書目名稱Global Virology III: Virology in the 21st Century讀者反饋學(xué)科排名

愛(ài)花花兒憤怒

Non-immune Modulators of Cellular Immune Surveillance to HIV-1 and Other Retroviruses: Future Artifn, and of related cell populations that act to control and dampen cellular immune reactivity. Contemporaneously, these soluble immune factors trigger non-immune cells to release of non-immune soluble factors, including pituitary and adrenocortical hormones (e.g., glucocorticoids), which finely modul

鉆孔

Emerging Technologies for Antiviral Drug Discovery, critical role in gene discovery (linking host and viral genes to disease), target validation (often protein targets for disease control), and molecular screening of small molecule inhibitors to protein targets. An integrated approach relating data from clinical virology, genomics, proteomics, gene

Obvious

載貨清單

Schlemms-Canal

Drug Development for Hepatitis C Virus Infection: Machine Learning Applications,ity against a broad spectrum of drug resistant viral variants. Drug discovery and design are highly complex, time consuming, and expensive endeavors. Therefore, it is crucial to incorporate new technologies for this process. Modern drug design strategies include ligand-based (LBDD) and structure-bas

Schlemms-Canal

Modern Developments in Short Peptide Viral Vaccine Design,ped, defined, named, and made available at the IMGT./HLA database (Immuno Polymorphism Database?– ImMunoGeneTics Database/Human Leukocyte Antigen) for public access. Identification of short peptide antigens capable of binding specifically to the human host HLA alleles is now possible using computer-

inflame

Artificial Life and Therapeutic Vaccines Against Cancers that Originate in Viruses,ethods that through a process of artificial life, allow to simulate the interactions that arise between human immune system, pathogen (viruses as etiological agents of cancer), and therapeutic vaccines to treat lesions that originates in the activity of this type of pathogen.

黑豹

手段

Swarm Intelligence in Cell Entry Exclusion Phenomena in Viruses and Plasmids: How to Exploit Intellerference phenomena within the abstract framework of swarm intelligence, where viral or plasmid genomes are being viewed as individual ‘a(chǎn)gents’. Signaling between mobile agents is a crucial element of swarm intelligence. Thus, in superinfection interference, the denial of cell entry to the superinfe